Delivery Order SPE2DB25D3201-SPE2DB25FNVRC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $33,849.19 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $47,074.22 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes to be delivered to Conshohocken, Pennsylvania. The contract is competitively awarded with no set-aside designation and employs firm fixed-price pricing, with an ultimate completion date of June 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $104,401.38 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,512.55 by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $731,676.74 from the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,095.48 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025. This firm fixed-price contract, with a completion date of September 2, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $74,668.50 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside provisions, is scheduled for completion by August 26, 2025 and will be performed at the company's Conshohocken facility. This award represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $51,783.70 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed price, competitively awarded contract (No Set-Aside Used) represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $237,676.14 delivery order by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price contract represents a child delivery order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $477,258.80 delivery order on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by July 29, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVRCDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $74,758.45 by the Defense Logistics Agency on August 14, 2025, for the supply of Wezlana 90 mg/mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 15, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contracting portfolio demonstrates significant capability in fulfilling diverse pharmaceutical and medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards consistently reflect firm fixed-price delivery orders across therapeutic domains including specialty medications, vaccines, and medical devices. No set-aside designation was applied to this award, indicating it was awarded through open competition, consistent with the contractor's broader procurement history with the Defense Logistics Agency's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.8k | 8/14/25 |